NasoPore and OtoPore bioresorbable dressings
Stryker’s NasoPore and OtoPore dressings support healing by absorbing fluids, minimizing edema, preventing adhesions, and clearing naturally through the body. With varied sizes, fragmentation times, compression strengths, you can select the ideal option for your patient’s needs.
Our bioresorbable dressings are designed for patient comfort and convenience while providing you simplicity and ease-of-use.
75%
of patients could not tell which nostril the dressing was in, a testament to the natural feel and comfort of NasoPore dressing6*.
100%
synthetic; no biological components.
*NasoPore and OtoPore
NasoPore nasal dressing is a 100% synthetic polymer and serves as a reliable stent for 36 to 48 hours2 after placement. By keeping its integrity for those critical hours, NasoPore can help minimize postoperative complications and bleeding.3 It comes in a wide variety of options - fast degrading, standard, firm and extra firm - to allow you to provide the best option for your patient's needs.
NasoPore
Depending on the option selected, it dissolves naturally within 7–14 days.
NasoPore Fast Degrading
The fast-degrading option naturally dissolves within 5-7 days.
OtoPore bioresorbable ear dressing
OtoPore ear dressing is a synthetic polymer and serves as a reliable stent for 36 to 48 hours4 after placement. By keeping its integrity for those critical hours, OtoPore can help minimize postoperative complications and bleeding5. It’s available in cylinder standard, cylinder forte, and ear square forte to match different clinical needs.
Any questions? Please send us a message. Our teams will get back to you shortly.
1. NasoPore IFU
2. Data on file at Stryker DHF D0000051300NAV
3. NasoPore instructions for use 5400-030-700
4. Data on file at Stryker DHF D0000051302NAV
5. OtoPore instructions for use 5400-030-701
6. Kastl KG, Reichart M, Scheithauer MO, et al. Patient comfort following FESS and NasoPore packing, a double blind prospective, randomized trial. Rhinology.2014;52(1):60-65.
* In 47 patients, 75% (35 individuals) were unable to identify the nostril in which the dressing had been placed.
ENT-BIO-SYK-2400599_REV-0